Safety, Tolerability and Immunogenicity of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and Radiofrequency Ablation in Patients With Advanced Solid Tumors
Latest Information Update: 25 Sep 2021
At a glance
- Drugs INeo Vac P01 (Primary) ; Granulocyte macrophage colony stimulating factor; Programmed cell death 1 receptor antagonists
- Indications Liver metastases; Solid tumours
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 04 May 2021 New trial record